SAN FRANCISCO, June 2, 2024 /PRNewswire/ -- FrogData (www.frogdata.com), the trailblazer in data-driven decision-making solutions for automotive dealerships, today announced…
The PRIMED study found a way to reduce treatment-related side effects among participants, decreasing dose reductions, treatment interruptions, and permanent…
-Trial-in-Progress poster provides overview on PEMDA-HN trial evaluating danvatirsen in combination with KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in patients with recurrent/metastatic…